Lithiases urétérales, quel traitement ? by Marti, A, Jichlinski, P, Leisinger, H.J

Get full text

GENE THERAPY MODEL FOR THE NGF DEPENDENCE AS DETERMINANT FOR THE RESISTANCE TO THE ANTI-ANDROGEN THERAPY by Tasinato, A., Tawadros, T., Darban, R., Deperthes, D., Leisinger, H.J., Jichlinski, P.

Get full text

FORCED DIURESIS IMPROVES THE DIAGNOSTIC ACCURACY OF 18F-FDG PET IN THE ABDOMEN AND PELVIS by Vaucher, L., Kamel, M.E., Schmidt, S., Prior, J., Leisinger, H.J., Bischof Delaloye, A., Patrice, J.

Get full text

HUMAN KALLIKREIN 2 (HK2) INHIBITORS SUPPRESS TUMOUR GROWTH OF PROSTATE CANCER XENOGRAFTS IN NUDE MICE by Kündig, C., Cloutier, S., Aellen, S., Felber, L., Chagas, J., Gygi, C., Jichlinski, P., Leisinger, H.J., Diamandis, E., Deperthes, D.

Get full text

822 Development of a new 3-D human in vitro model mimicking tumour-normal cell interactions in photodynamic applications for bladder cancer by Cloutier, S., Deperthes, D., Kucera, P., Frey, P., Danielsson, C., Leisinger, H.j., Jichlinski, P.

Get full text

PEPTABODY-EGF: A NOVEL APOPTOSIS INDUCER TARGETING ERBB1 RECEPTOR OVEREXPRESSING CANCER CELLS by Kündig, C., Fattah, O., Rotman, S., Cloutier, S., Felber, L., Gygi, C., Jichlinski, P., Leisinger, H.J., De Witte, P., Thalmann, G., Mach, J.P., Deperthes, D.

Get full text